文献速递血栓与止血

2B型血管性血友病的遗传变异、血小板减少与临床表型:中位16年随访研究

Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.
PubMed 文献 · J Thromb Haemost · 2024-09-28

该研究纳入64例经基因确诊的2B型血管性血友病患者,回顾性分析基因型与血小板减少、出血表型及内皮活化事件的关联,中位随访16年。结果显示67.2%患者出现血小板减少,p.Arg1306Trp变异是血小板减少的最重要决定因素(比值比25.1),但血小板减少与累积出血评分或年出血率无关联。

要点

  • 2B型血管性血友病患者中67.2%出现血小板减少,p.Arg1306Trp变异者达75.0%,p.Arg1308Cys变异者为58.3%。
  • p.Arg1306Trp变异是血小板减少的最重要决定因素,比值比25.1。
  • 8次足月妊娠中4名女性孕晚期血小板下降,8次分娩中5次发生产后出血(估计失血量>500 mL)。

核心结论

  • 本研究发现2B型血管性血友病患者中VWF变异p.Arg1306Trp与血小板减少存在强关联。

研究设计与样本

  • 研究纳入来自荷兰全国多中心「Willebrand in the Netherlands」研究的64例经基因确诊的2B型血管性血友病患者,回顾性收集电子病历中的临床和实验室数据,中位随访16年。

主要发现

  • 血小板减少见于67.2%的患者,不同遗传变异间发生率不同(p.Arg1306Trp:75.0%,p.Arg1308Cys:58.3%)。
  • 血小板减少的最重要决定因素是p.Arg1306Trp VWF变异(比值比25.1)。
  • 血小板计数随时间强烈波动,p.Arg1306Trp患者中37.5%持续低于150×10^9/L,p.Arg1308Cys患者中为8.3%。
  • 在本分析中,内皮活化不是血小板减少发生的独立决定因素(比值比1.3)。
  • 未发现血小板减少与累积出血评分或年出血率之间存在关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type 2B von Willebrand disease (VWD) is a bleeding disorder caused by gain-of-function variants in the VWF gene. The laboratory and clinical phenotype of type 2B VWD is heterogeneous. OBJECTIVES: We investigated associations between genotype and phenotype over a median of 16 years follow-up in a large cohort of well-characterized patients. METHODS: We included 64 genetically confirmed type 2B VWD patients from the national multicenter "Willebrand in the Netherlands" study and retrospectively collected clinical and laboratory data from electronic patient records. We analyzed associations between genotype and thrombocytopenia, bleeding phenotype, and events leading to endothelial activation and von Willebrand factor (VWF) secretion, including surgery, desmopressin administration, pregnancy, and delivery. RESULTS: Thrombocytopenia manifested in 67.2% of patients, with varying occurrences between genetic variants (p.Arg1306Trp: 75.0%, p.Arg1308Cys: 58.3%). The most important determinant of thrombocytopenia was the p.Arg1306Trp VWF variant (odds ratio, 25.1). Platelet counts strongly varied over time and were continuously <150 × 109/L in 37.5% of patients with p.Arg1306Trp vs 8.3% in p.Arg1308Cys. In our analysis, endothelial activation was not an independent determinant (odds ratio, 1.3) for thrombocytopenia occurrence. No association was found between thrombocytopenia and cumulative bleeding scores or annual bleeding rates. Four women showed declining platelet counts in all full-term pregnancies (n = 8) during the third trimester with a sharp decrease in the week before delivery. Postpartum hemorrhage, defined as >500 mL estimated blood loss at delivery, occurred in 5 of 8 deliveries, despite prophylactic treatment with VWF concentrates. CONCLUSION: This study reveals a strong association between VWF variant p.Arg1306Trp and thrombocytopenia in type 2B VWD patients.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. van Kwawegen CB, Atiq F, Endenburg D, et al. Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study. J Thromb Haemost. 2024. PMID: 39343102. doi:10.1016/j.jtha.2024.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。